Osteoporosis in mixed connective tissue disease

Clinical Rheumatology

Volumn 22, Issue 3, 2003, Pages 213-217

  Bodolay, E ^a   Bettembuk, P ^a   Balogh, A ^a   Szekanecz, Z ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

Author keywords

Dehydroepiandrosterone sulphate; Mixed connective tissue disease (MCTD); Oestradiol; Osteocalcin; Osteoporosis; Testosterone

Indexed keywords

ESTRADIOL; OSTEOCALCIN; PRASTERONE SULFATE; PREDNISOLONE; SEX HORMONE; TESTOSTERONE;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BONE DENSITY; BONE MINERAL; CELL FUNCTION; COMORBIDITY; CONTROLLED STUDY; CORTICOSTEROID INDUCED OSTEOPOROSIS; DISEASE COURSE; DUAL ENERGY X RAY ABSORPTIOMETRY; ESTRADIOL BLOOD LEVEL; FEMALE; FEMUR NECK; HUMAN; LUMBAR SPINE; MAJOR CLINICAL STUDY; MIXED CONNECTIVE TISSUE DISEASE; OSTEOBLAST; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SCORING SYSTEM; TESTOSTERONE BLOOD LEVEL;

AGE DISTRIBUTION; AGED; BONE DENSITY; CASE-CONTROL STUDIES; COHORT STUDIES; COMORBIDITY; DENSITOMETRY, X-RAY; ESTROGENS; FEMALE; HUMANS; INCIDENCE; MIDDLE AGED; MIXED CONNECTIVE TISSUE DISEASE; OSTEOCALCIN; OSTEOPOROSIS, POSTMENOPAUSAL; PROBABILITY; PROGNOSIS; SEVERITY OF ILLNESS INDEX; STATISTICS, NONPARAMETRIC;

EID: 0141962638     PISSN: 07703198     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10067-003-0701-x     Document Type: Article

References (22)

1. Kalla AA, Fataar AB, Jessop SJ, Bewerunge L (1993) Loss of trabecular bone mineral density in systemic lupus erythematosus. Arthritis Rheum 36: 1726-1734
2. Formiga F, Moga I, Nolla JM (1995) Loss of bone mineral density in premenopausal women with systemic lupus erythematosus. Ann Rheum Dis 54: 274-276
3. Canalis E, McCarthy TL, Centrella M (1991) Growth factors and cytokines in bone cell metabolism. Annu Rev Med 42: 17-28
4. Szekanecz Z, Elek I, Szegedi Gy (1998) Rheumatoid arthritis-associated osteoporosis [Hungarian]. Calcium Bone 1: 45-51
5. Henderson NK, Sambrook PN (1996) Relationship between osteoporosis and arthritis and effect of corticosteroids and other drugs on bone. Curr Opin Rheumatol 8: 365-369
6. Horowitz MC (1993) Cytokines and estrogen in bone. Science 260: 626-628
7. Manolagas SC, Jilka RL (1995) Bone marrow, cytokines and bone remodelling. N Engl J Med 332: 305-311
8. Deodhar AA, Woolf AD (1996) Bone mass measurement and bone metabolism in rheumatoid arthritis: a review. Br J Rheumatol 35: 309-322
9. Di Munno O, Mazzantini M, Massei P et al (1995) Reduced bone mass and normal calcium metabolism in systemic sclerosis with and without calcinosis. Clin Rheumatol 14: 407-412
10. Lahita RG, Bradlow L, Fishman J, Kunke HG (1993) Estrogen metabolism in systemic lupus erythematosus. Patients and family members. Arthritis Rheum 25: 843-846
11. Cortet B, Flipo RM, Cortet B et al (1997) Evaluation of bone mineral density in patients with rheumatoid arthritis, influence of disease activity and glucocorticoid therapy. Rev Rhum [Engl Edn] 64: 451-458
12. Lems WF, Gerrits MI, Jacobs JW (1996) Changes in markers of bone metabolism during high dose corticosteroid pulse treatment in patients with rheumatoid arthritis. Ann Rheum Dis 55: 288-293
13. Dhillon VB, Davies MC, Hall ML (1990) Assessment of the effect of oral corticosteroids on bone mineral density in systemic lupus erythematosus. Ann Rheum Dis 49: 624-626
14. Hameenkorpi R, Ruuska P, Forsberg S (1993) More evidence of distinctive features of mixed connective tissue disease. Scand J Rheumatol 22: 63-68
15. Bodolay E, Szegedi G (1989) Clinical observations in mixed connective tissue disease [Hungarian]. Orv Hetil 130: 557-561
16. Lundberg I, Nyman U, Petterson I, Hedfors E (1992) Clinical manifestations and anti(U1)snRNP antibodies: a prospective study of 29 anti-RNP antibody positive patients. Br J Rheumatol 31: 811-817
17. Berding G, Kirchhoff TD, Burchert W et al (1998) [18F]fluoride PET indicates reduced bone formation in severe glucocorticoid-induced osteoporosis. Nuklearmedizin 37: 76-79
18. Alarcon-Segovia D., Villareal D (1987) Classification and diagnostic criteria for mixed connective tissue disease. In: Mixed connective tissue disease and antinuclear antibodies. Amsterdam: Elsevier, 32
19. Cortet B, Flipo RM, Pigny P (1998) Is bone turnover a determinant of bone mass in rheumatoid arthritis? J Rheumatol 25: 2339-2344
20. Hall GM, Spector TD, Delmas PD (1995) Markers of bone metabolism in postmenopausal women with rheumatoid arthritis. Arthritis Rheum 38: 902-906
21. Garnero P, Jouvenne P, Buchs N et al (1999) Uncoupling of bone metabolism in rheumatoid arthritis patients with or without joint destruction: assessment with serum type I collagen breakdown products. Bone 24: 381-385
22. Masi AI, Josipovic DB, Jefferson WE (1984) Low adrenal androgenic-anabolic steroids in women with rheumatoid arthritis: gas-liquid chromatographic studies of RA patients and matched normal women indicating decreased 11-deoxy-17-ketosteroid excretion. Semin Arthritis Rheum 14: 1-23